0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Haematology

Buy Now

Phase 1 Cancer Clinical Trials - A Practical Guide (Paperback, New) Loot Price: R2,390
Discovery Miles 23 900
Phase 1 Cancer Clinical Trials - A Practical Guide (Paperback, New): Elizabeth A. Eisenhauer, Christopher Twelves, Marc Buyse

Phase 1 Cancer Clinical Trials - A Practical Guide (Paperback, New)

Elizabeth A. Eisenhauer, Christopher Twelves, Marc Buyse

 (sign in to rate)
Loot Price R2,390 Discovery Miles 23 900 | Repayment Terms: R224 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

Phase I trials are a critical first step in the study of novel therapeutic approaches. They follow years of development in the laboratory, and precede Phase II and III trials where testing of the drug becomes more focused yet is conducted on a wider scale. The primary goals of Phase I trials are to identify the recommended dose, schedule and pharmacologic behaviour of new agents or new combinations of agents, and to describe the adverse effects of treatment. In cancer therapeutics, such studies have particular challenges. In general, because of the nature of the effects of treatment, most studies are conducted in patients with advanced malignancy, rather than in healthy volunteers. Furthermore, the endpoints of these trials are usually measures of adverse effects, but increasingly investigators are interested in assessment of the effects of new drugs on their molecular target. These factors render the design, conduct, analysis and ethical aspects of Phase I cancer clinical trials unique. This book provides a practical guide to Phase I cancer trials and is appropriate for oncology trainees or specialists interested in understanding cancer drug development. Topics covered include preclinical requirements needed for first-in-man investigation of new agents, principles and statistical design, ethical considerations of Phase I studies, pharmacokinetics, pharmacodynamics, and studies in special populations. Practical information on protocol development, study activation and conduct, as well as how to write reports of the results, are incorporated. Numerous appendices offer document templates to use in Phase I study development, and examples from actual Phase I trials are interspersed throughout, making this a true 'hands-on' guide. In an exciting time in cancer research, as the number and type of new potential anti-cancer drugs is increasing dramatically, this book provides much needed information on the first stage in getting a drug approved.

General

Imprint: Oxford UniversityPress
Country of origin: United Kingdom
Release date: July 2006
First published: August 2006
Authors: Elizabeth A. Eisenhauer • Christopher Twelves • Marc Buyse
Dimensions: 232 x 151 x 20mm (L x W x T)
Format: Paperback
Pages: 360
Edition: New
ISBN-13: 978-0-19-856719-6
Categories: Books > Medicine > Clinical & internal medicine > Haematology
Books > Medicine > Other branches of medicine > Pharmacology > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
Promotions
LSN: 0-19-856719-7
Barcode: 9780198567196

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners